IGPA Statement on the Trans-Pacific Partnership (TPP) Negotiations
The Asia-Pacific Region is of key importance to the generic pharmaceutical industry. It is the location of hundreds of generic manufacturing facilities and strategic export opportunities. It is also an important source of pharmaceutical ingredients and other raw material inputs for our high-quality, low-cost medicines. As such, IGPA strongly supports efforts to expand trade in the region through the Trans-Pacific Partnership (TPP) negotiations.
